- Home
- GV vs PPBT Comparison
GV vs PPBT Comparison
Compare GV & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- PPBT
- Stock Information
- Founded
- GV 2013
- PPBT 2010
- Country
- GV Canada
- PPBT Israel
- Employees
- GV N/A
- PPBT N/A
- Industry
- GV Other Consumer Services
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- PPBT Health Care
- Exchange
- GV Nasdaq
- PPBT Nasdaq
- Market Cap
- GV 7.8M
- PPBT 6.3M
- IPO Year
- GV 2022
- PPBT N/A
- Fundamental
- Price
- GV $2.09
- PPBT $2.62
- Analyst Decision
- GV
- PPBT Strong Buy
- Analyst Count
- GV 0
- PPBT 1
- Target Price
- GV N/A
- PPBT $33.00
- AVG Volume (30 Days)
- GV 71.3K
- PPBT 31.7K
- Earning Date
- GV 06-17-2025
- PPBT 05-21-2025
- Dividend Yield
- GV N/A
- PPBT N/A
- EPS Growth
- GV N/A
- PPBT N/A
- EPS
- GV N/A
- PPBT N/A
- Revenue
- GV $7,773,905.00
- PPBT N/A
- Revenue This Year
- GV N/A
- PPBT N/A
- Revenue Next Year
- GV N/A
- PPBT N/A
- P/E Ratio
- GV N/A
- PPBT N/A
- Revenue Growth
- GV N/A
- PPBT N/A
- 52 Week Low
- GV $1.00
- PPBT $2.00
- 52 Week High
- GV $9.60
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- GV 50.62
- PPBT 56.64
- Support Level
- GV $2.03
- PPBT $2.46
- Resistance Level
- GV $2.15
- PPBT $2.80
- Average True Range (ATR)
- GV 0.16
- PPBT 0.20
- MACD
- GV 0.03
- PPBT 0.04
- Stochastic Oscillator
- GV 47.90
- PPBT 66.96
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.